Antiverse
About
What does Antiverse do?
Antiverse is a biotechnology company that utilizes artificial intelligence to accelerate antibody discovery and development. Their platform aims to significantly reduce the time and cost associated with bringing new antibody-based therapeutics to market.
What is Antiverse's revenue?
StartupHub estimates Antiverse's annual revenue at $4.3M (range $2.3M to $11.8M, 68% confidence), based on comparable companies in the sector.
What is Antiverse's valuation?
StartupHub estimates Antiverse's effective valuation at $60.2M (range $39.3M to $94.2M, 23% confidence), based on comparable companies in the sector.
How much funding has Antiverse raised?
Antiverse has raised a total of $16M in funding. The most recent round on record is Series A.
Where is Antiverse headquartered?
Antiverse is headquartered in London, England, United Kingdom.
When was Antiverse founded?
Antiverse was founded in 2018.
What industry does Antiverse operate in?
Antiverse operates in Biotechnology, Artificial Intelligence, Drug Discovery, Pharmaceuticals.
How many employees does Antiverse have?
Antiverse has approximately 28 people on record.
No comments yet. Be the first to share your take.